High-Tech Grunderfonds

High-Tech Gründerfonds Management GmbH, established in 2005 and based in Bonn, Germany, is a venture capital firm that specializes in early-stage investments in high-tech startups across various sectors, including information and communication technology, software, healthcare, and life sciences. The firm focuses on companies that are less than one year old and have a turnover of less than €10 million. High-Tech Gründerfonds typically invests between €0.5 million and €3 million, acquiring a minority stake of up to 25% in its portfolio companies. The firm often acts as the lead investor and provides follow-on financing, having facilitated over €2 billion in additional funding from external investors. With a commitment to nurturing innovation, it has supported the development of more than 500 startups and has successfully exited over 100 investments. The firm’s backing includes participation from various public and private entities, reflecting its role as a key player in the German startup ecosystem.

Marie Asano

Investment Manager

Michael Brandkamp Ph.D

Managing Director

Tobias Faupel

Principal

Bernd Georgen

Partner

Bernd Goergen

Partner

Gregor Haidl

Investor

Ansgar Kirchheim

Partner

Lena Krzyzak

Principal

Maurice Kügler

Investor

Klaus Lehmann

Partner

Kristin Müller

Investment Manager

Claudia Raber

Partner Relationship Management

Frank Reinecke

Partner

Romy Schnelle

Managing Director

Michael Strzyz

Investment Manager

Past deals in Series A

Dualyx

Series A in 2023
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.

Kranus Health

Series A in 2022
Kranus Health is a global provider for Men‘s Health Digital Therapeutics. Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.

Code Intelligence

Series A in 2022
Code Intelligence GmbH, founded in 2017 and based in Bonn, Germany, specializes in developing security software aimed at enhancing the reliability and security of software applications. The company offers modern security testing solutions utilizing coverage-based fuzzing techniques, which enable automated vulnerability detection and error checking with minimal expert intervention. Its products are designed for use by software developers, quality managers, and IT security firms, facilitating a continuous testing infrastructure that integrates the latest advancements in software testing technology. Code Intelligence serves prominent global clients, including Bosch, Deutsche Börse Group, and Deutsche Telekom, helping them ensure the security and robustness of their software systems.

Venly

Series A in 2022
Arkane takes care of the complexity so you can offer a Web 2.0 experience while using the power of blockchain under the hood

Neural Concept

Series A in 2022
Neural Concept is a software company that employs deep learning algorithms to transform the industrial engineering process. This allows companies to focus on core strategic design choices, speed up R&D cycles, and reduce computational costs. The company was established in 2018 and is based in Lausanne, Switzerland.

Sunvigo

Venture Round in 2022
Sunvigo provides you with cheap solar power from your roof and real green power from the grid.

INERATEC

Series A in 2022
Provider of sustainable e-fuels and synthetic chemical products intended to replace fossil crude oil. The company specializes in producing renewable hydrogen and greenhouse gases such as carbon dioxide and hydrogen which are then converted into e-kerosene, carbon dioxide-neutral diesel, synthetic waxes, or methanol, enabling chemical plant operators to run their entire chemical plants using synthetic fuels using climate-neutral energy with reduced chemical waste and more climate protection.

Ceregate

Series A in 2022
CereGate GmbH, founded in 2019 and headquartered in Hamburg, Germany, with an additional office in San Diego, California, focuses on developing innovative brain-machine interface technology. The company's software platform enhances the programming of neuromodulation systems, including implants placed in the brain or spinal cord. This technology aims to support patients with neurological disorders or sensory deficits by enabling novel therapeutic approaches and improving their ability to adapt and manage their conditions independently. CereGate's advancements pave the way for new communication methods and therapeutic options, contributing to significant improvements in patient outcomes.

Blickfeld

Series A in 2021
Blickfeld GmbH manufactures light detection and ranging (LiDAR) sensors. Its product helps to survey near-infrared light to detect the shape of objects, allowing autonomous vehicles to see, and analyze the world around them. The company also develops object detection and mapping software which measures the data provided by the sensors and helps in city planning, connected mobility, real-time mapping, and usage pattern analysis. The company caters to automotive, transportation, industrial, and robotics sectors. The company was founded in 2016 and is based in Munich, Germany.

Emergence Therapeutics

Series A in 2021
Emergence Therapeutics AG develops novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers. The company was incorporated in 2019 and is based in Duisburg, Germany.

Abalos Therapeutics

Series A in 2021
The company intends to use the funds to advance its arenavirus-based lead candidates towards clinical testing. They will develop the initial product candidates using its proprietary Fast Evolution platform, which will generate virus strains with optimized anti-tumoral properties. These candidates will be selected based on their ability to re-program the immune system to specifically and efficiently eliminate the malignant tumor tissue.

Workpath

Series A in 2021
Workpath is the leading enterprise software provider enabling organizations to execute their strategies fast, flexible and effective in an increasingly dynamic and complex world. With simple and intuitive workflow tools Workpath engages all employees in the strategy and execution process. Its comprehensive analytics suite empowers executives to make better decisions on when to adapt focus, budgets or structures as early as possible.

Urban Ground

Series A in 2021
End to end digital lettings services fostering Tenancy as a Service

Qnami

Series A in 2021
Qnami AG manufactures non-invasive sensors. Its products include ProteusQ, non-invasive magnetic imaging microscope; and Quantum Diamond, which includes Quantilevers MX, diamond probes containing a single NV for high resolution magnetic imaging, and NV diamond membranes, ready-to-use diamond with NV centers. Its applications are multiferroic antiferromagnet, antiferromagnetic ram, microwave imaging, magnetic nanomemories, and superconductivity. Qnami AG was founded in 2017 and is based in Basel, Switzerland.

Sdui

Series A in 2021
Sdui GmbH, founded in 2017 and based in Koblenz, Germany, offers a digital platform designed to enhance communication within educational institutions. The platform simplifies interactions between teachers, parents, and students by providing features such as messaging, class schedules, parent letters, and room bookings. By digitizing essential processes, Sdui aims to reduce administrative burdens and improve organizational efficiency in schools. Over a short period, the company has gained traction in the educational market, reaching hundreds of institutions and establishing a strong reputation for its user-friendly solutions.

Actitrexx

Series A in 2021
Developer of a cell therapy technology designed for the treatment of patients after a stem cell transplant to prevent rejection reactions. The company's technology focuses on the development of clinical testing of cell therapeutics for the suppression of transplant rejection and autoimmunity and the portfolio of cell therapy, enabling patients to prevent the fatal consequences of rejection, significantly improving their quality of life, and also opening up to many therapy options.

GeneQuine Biotherapeutics

Series A in 2021
GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.

Filestage

Series A in 2021
Filestage GmbH, founded in 2015 and based in Stuttgart, Germany, offers a web application designed to facilitate the review and approval of media content, including videos, designs, and documents. The platform enables users to share files with clients and colleagues, gather visual feedback, and manage the approval process without requiring reviewers to sign up. Filestage streamlines communication by allowing users to annotate comments directly within the files, thus eliminating the inefficiencies of email exchanges. The application includes features for tracking review statuses, managing revisions, and automating to-do lists, making it particularly useful for advertising agencies, video production studios, designers, consulting firms, and brands globally.

talpasolutions

Series A in 2020
talpasolutions a predictive SaaS analytics provider for the mining industry that helps companies optimize machine performance, reduce breakdowns, and improve safety by making data more understandable. talpasolutions makes it possible for operators and machine manufacturers in heavy industry to use machine data that would have otherwise been lost. talpasolutions concentrates on building visualization and analysis applications for the industrial internet. In the first step, large amounts of data from the machines are recorded. Comprehendable visualizations allow for different stakeholders to understand relationships based on sensor data and contextual data and to react to critical information, which would otherwise have been buried in the data transfer. In the second step the newest predictive models are applied to eliminate events such as errors and the breakdown of machines critical to the process. This increases not only the availability but also the workload of the machines. talpasolutions has built a network out of industry partners to develop solutions that stretch across various sectors and unify industry experience, data science, and workflow connectivity. Using predictive instructions our platform recognizes problems before they occur and supports users with workflow-based processes. Our applications make it possible to collect performance data from machines in order to recommend optimal fleet combinations for respective scenarios to customers. This leads to more operating hours, higher efficiency, and an improved lifetime value of the machines.

Taxdoo

Series A in 2020
Taxdoo is a startup that bills itself as a compliance platform for the digital economy. Its platform collects relevant data from marketplaces, online shops, and ERP systems on a daily basis and processes it in line with international VAT regulations, respective of financial authorities through an international network of VAT experts, which can then be transferred into financial accounting systems. The company was founded in 2016 and is headquartered in Hamburg, Germany.

Synendos Therapeutics

Series A in 2020
Synendos Therapeutics AG is a biopharmaceutical company based in Allschwil, Switzerland, founded in 2019. The company focuses on developing innovative therapies for unmet needs in neuropsychiatric disorders, particularly anxiety, mood, and stress-related conditions. Synendos utilizes a novel drug target within the endocannabinoid system to restore the brain's natural functioning. Its therapies involve the modulation of cannabinoid activity and the inhibition of endocannabinoid transport across cell membranes, addressing altered neurotransmission in various brain regions. This approach presents a promising solution to the significant demand for effective pharmacological treatments, especially for conditions like post-traumatic stress disorder (PTSD), which currently lacks adequate therapeutic options.

troy

Series A in 2020
troy gmbh develops a debt collection platform. The company was founded in 2017 and is based in Lippstadt, Germany. troy gmbh operates as a subsidiary of TROY Group, Inc.

heartbeat medical

Series A in 2020
Heartbeat Medical develops a healthcare platform focused on tracking patient-reported outcomes. The platform serves as a comprehensive patient management tool suitable for healthcare facilities of all sizes. By emphasizing the importance of quality of life data, Heartbeat Medical enables healthcare providers to gain valuable insights through intelligent evaluations of diagnostics and treatment methods. This approach allows physicians and therapists to enhance their understanding of patient experiences and improve treatment strategies based on real-world evidence.

stimOS

Series A in 2020
stimOS GmbH develops a drug delivery biochemical procedure that initiates bone formation, anti inflammatory activity, and healing process. The company also develops technologies and procedures that refine, functionalize, and activate implant materials. It also offers research and development of implant materials and implant surfaces. stimOS GmbH was founded in 2015 and is based in Constance, Germany.

Tubulis

Series A in 2020
Tubulis GmbH, founded in 2019 and based in Munich, Germany, focuses on the research, design, and development of protein-drug conjugates by integrating proprietary technologies with disease-specific biology. The company aims to transform the therapeutic landscape by creating innovative antibody-drug conjugates (ADCs) that enhance treatment outcomes for patients. Tubulis is dedicated to identifying new protein-drug combinations for various therapeutic applications, thereby expanding the potential of ADCs in addressing unmet medical needs.

NovaPump

Series A in 2020
NovaPump GmbH, based in Jena, Germany, specializes in the research, development, and distribution of non-invasive and percutaneous heart assist devices. Established in 2012, the company is focused on its innovative PERKAT technology, a self-expanding heart pump designed for acute left or right heart failure patients. This device will be available in the forms of pLVAD and pRVAD heart pumps, integrating with existing intra-aortic balloon pump techniques to enhance treatment options. The PERKAT system is notable for being catheter-based, pulsatile, and ECG-triggered, offering a cost-effective solution with high pump performance. Although the device is not yet on the market, it has been the subject of scientific publications and presentations at major cardiology conferences, highlighting its medical necessity and technological advantages. The company's mission is to provide timely and effective treatment for patients suffering from severe heart conditions, ultimately improving their chances of recovery.

Kumovis

Series A in 2020
KUMOVIS GmbH manufactures 3D-printing systems for medical applications. Its products include KUMOVIS R1, a 3D printing system based on fused layer manufacturing for thermoplastic materials. The company offers systems designed to manufacture variety of medical products starting from prototyping up to personalized human implants. It provides 3D printer based manufacturing of industrial and medical applications. The company was founded in 2017 and is headquartered in Munich, Germany.

Noscendo

Series A in 2020
Noscendo GmbH is a diagnostics company based in Duisburg, Germany, specializing in bioinformatics solutions for identifying and assessing pathogens associated with bloodstream infections. Their diagnostic procedures utilize Next Generation Sequencing (NGS) technology, enabling intensive care clinicians to detect bacteria, fungi, viruses, and parasites present in patients' blood. Noscendo employs proprietary algorithms to evaluate the significance of each identified pathogen, thereby enhancing the accuracy and effectiveness of infection management in clinical settings.

Blickfeld

Series A in 2020
Blickfeld GmbH manufactures light detection and ranging (LiDAR) sensors. Its product helps to survey near-infrared light to detect the shape of objects, allowing autonomous vehicles to see, and analyze the world around them. The company also develops object detection and mapping software which measures the data provided by the sensors and helps in city planning, connected mobility, real-time mapping, and usage pattern analysis. The company caters to automotive, transportation, industrial, and robotics sectors. The company was founded in 2016 and is based in Munich, Germany.

Scipio Bioscience

Series A in 2020
Scipio Bioscience SAS is a biotechnology company based in Paris, France, specializing in the development and manufacture of benchtop kits designed for sample preparation in single-cell studies. Founded in 2017, the company offers innovative solutions that facilitate sequencing applications in both clinical and basic research, with a particular focus on transcriptomics. Their products enable single-cell barcoding in a test tube format, streamlining the process for researchers engaged in advanced biological studies.

Instagrid

Series A in 2020
Instagrid GmbH, founded in 2018 and based in Stuttgart, Germany, specializes in the manufacture of portable battery storage solutions. The company develops software-defined battery systems designed to provide advanced portable power supplies. Its products cater to various sectors, including construction, event technology, professional landscaping, garden and tree care, and public services, addressing the need for reliable and efficient power sources in diverse applications.

Selfapy

Series A in 2020
Selfapy GmbH is a Berlin-based company that provides online therapy programs aimed at individuals experiencing mental health challenges, particularly depression. Founded in 2016, Selfapy offers a range of therapy-related services, including programs focused on anxiety, eating disorders, stress management, and chronic panic. The company utilizes a guided self-help approach, allowing users to engage with exercises, videos, and texts over a three-month period, facilitated through phone or SMS interactions. These programs are designed to help users recognize negative thought patterns and develop healthier behaviors, all while ensuring anonymity and flexibility in the therapeutic process. Selfapy serves as a supportive tool for those seeking to improve their mental well-being.

envelio

Series A in 2019
Envelio GmbH, founded in 2017 and based in Cologne, Germany, specializes in developing software and algorithms for energy networks. Its primary offering is the Intelligent Grid Platform (IGP), a modular software system designed to assist distribution grid operators in digitizing and automating grid planning and operation processes. The IGP includes applications for data quality, which connects isolated data systems to identify and correct errors, as well as planning applications that automate grid planning tasks. Additionally, IGP operation applications provide recommendations for managing congestion in the grid during potential bottlenecks. By leveraging artificial intelligence and mathematical optimization, Envelio supports the integration of numerous distributed energy resources and smart meter data, addressing the challenges posed by the evolving energy landscape.

troy

Series A in 2019
troy gmbh develops a debt collection platform. The company was founded in 2017 and is based in Lippstadt, Germany. troy gmbh operates as a subsidiary of TROY Group, Inc.

Abalos Therapeutics

Series A in 2019
The company intends to use the funds to advance its arenavirus-based lead candidates towards clinical testing. They will develop the initial product candidates using its proprietary Fast Evolution platform, which will generate virus strains with optimized anti-tumoral properties. These candidates will be selected based on their ability to re-program the immune system to specifically and efficiently eliminate the malignant tumor tissue.

Remind.me

Series A in 2019
Remind.me GmbH operates an online platform that offers reminder and optimization services specifically for contracts and insurance policies. Founded in 2017 and based in Berlin, the service allows users to input their contractual information, set reminders for expiry dates, and receive notifications about opportunities to optimize their contracts. Additionally, the platform provides access to online deals for various products and services, including the most affordable electricity and gas tariffs. The service is free for consumers, as it generates revenue through agency commissions from partners when users choose to finalize contracts. Remind.me aims to help users save money by ensuring they are aware of contract deadlines and can access the best available deals in the market.

Remind.me

Series A in 2019
Remind.me GmbH operates an online platform that offers reminder and optimization services specifically for contracts and insurance policies. Founded in 2017 and based in Berlin, the service allows users to input their contractual information, set reminders for expiry dates, and receive notifications about opportunities to optimize their contracts. Additionally, the platform provides access to online deals for various products and services, including the most affordable electricity and gas tariffs. The service is free for consumers, as it generates revenue through agency commissions from partners when users choose to finalize contracts. Remind.me aims to help users save money by ensuring they are aware of contract deadlines and can access the best available deals in the market.

MoBerries

Series A in 2019
MoBerries is a network that connects companies and professionals. MoBerries mission is to revolutionize the old fashioned recruitment processes, offering networking software with a unique real-time matching algorithm, tailored to both professionals as well as partners. The system enables employers to expand their reach when sourcing high-quality candidate leads for their job openings without wasting precious time and resources. The added value for professionals is that MoBerries provides them qualified leads for potentially matching positions.

Alentis Therapeutics

Series A in 2019
Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.

Cytena

Series A in 2019
cytena GmbH develops a laboratory device to separate single cells. Its products include singlecell printer, c.sight, b.sight, f.sight, and cartridge. The company offers its single cell printer technology for applications in cell line development, single cell genomic, and application development, including research and development aspects. The company was founded in 2014 and is headquartered in Freiburg, Germany with distribution networks in Europe, North America, India, Asia, and the United Kingdom. As per the transaction announced on August 5, 2019, cytena GmbH operates as a subsidiary of Cellink AB (publ).

IPlytics

Series A in 2019
IPlytics GmbH develops an online based patent analytics platform to analyze organization’s market developments, technology trends, and competitive positions for patenting and standardization. Its platform integrates patent analysis, valuations, mapping, and landscaping, as well as a mapping of technology standards and products, such as an identification of standard essential patents, patent licensing terms, or patent pools. The company’s platform also facilitates decision making in the areas, such as patent positioning, patentability, investments, portfolio planning, licensing cost, standardization opportunities, emerging technologies, and new markets and alliances. In addition, it offers technology landscaping analysis, patent valuation measures, and technology watch analysis. The company serves scientific research organizations. IPlytics GmbH was founded in 2012 and is based in Berlin, Germany.

gridscale

Series A in 2019
gridscale GmbH is a cloud computing provider based in Bedburg, Germany, specializing in Infrastructure as a Service (IaaS) solutions for both businesses and individual developers. Founded in 2014, the company offers a highly automated platform that allows users to manage cloud servers and customize infrastructure resources according to their specific needs. Their services include virtual cloud servers, storage, network resources, and complementary Platform as a Service (PaaS) components such as load balancers and firewalls. gridscale’s architecture is designed to integrate seamlessly into existing corporate systems, enabling clients to focus on their core business activities without the complexities of managing cloud infrastructure. This approach is particularly valuable in an era of increasing data complexity and volume.

Iconic Lab

Series A in 2019
Iconic envisions a tokenized economy where blockchain and cryptographic technology enable inclusive, transparent and secure financial markets. We are the bridge enabling enterprise-grade crypto asset investment opportunities as the tokenization of financial and real-world assets enhance financial institutional markets. Our team brings a wealth of professional, financial experience and a proven track record in the digital assets and blockchain industry. Our business units deliver excellence, providing the quality assurances investors expect from a world-class asset manager, as we champion our mission to decentralize wealth generation.

Mecuris

Series A in 2019
Mecuris is a company based in Munich, Germany, that specializes in the development of custom-made orthopedic solutions, including orthoses and prostheses. Founded in 2016, Mecuris aims to enhance the lives of wearers by enabling orthopedic professionals to co-create personalized products through its innovative Mecuris Solution Platform. This platform leverages patient data and scans to semi-automatically generate individualized 3D designs, which are then prepared for printing at local 3D printing hubs. By streamlining the design and manufacturing process, Mecuris significantly reduces production times by 75%, allowing for a completely customized fit and functionality tailored to each user. The company’s digital approach and expertise in 3D printing position it as a key player in the orthopedic and prosthetic industry, facilitating rapid delivery of bespoke solutions.

Atriva Therapeutics

Series A in 2019
Atriva Therapeutics GmbH is a biopharmaceutical company based in Tübingen, Germany, focused on developing antiviral therapies targeting seasonal and pandemic influenza as well as other respiratory viral infections. Founded in 2015, the company is advancing its lead candidate, ATR-002, a Mitogen-activated protein kinase inhibitor, which has successfully completed preclinical development. Atriva has also sought scientific advice from a European regulatory authority to ensure compliance and receive guidance on its preclinical development program and the upcoming Phase I study of ATR-002 involving healthy volunteers.

PreOmics

Series A in 2018
PreOmics develops and provides innovative tools for customers around the world for mass spectrometry (MS)-based proteomics using cutting-edge technologies to support researchers in their protein analysis needs. PreOmics is as a spin-off company from the proteomics research group of pioneer Matthias Mann at the Max-Planck Institute of Biochemistry. They at PreOmics develop and provide innovative technologies for mass spectrometry-based proteomics to make your research simply better. Their mission is to provide you with the best possible solutions and at the highest quality to achieve your results faster, easier and in a more robust manner than ever before.

Volterion

Series A in 2018
Volterion GmbH manufactures and sells compact size redox flow batteries for private homes for the storage of renewable energies. The company offers redox flow stacks, redox flow modules, and redox flow systems. The company was founded in 2015 and is headquartered in Dortmund, Germany.

Wirelane

Series A in 2018
Wirelane is a full service provider in the field of electric mobility. The company is currently active in 5 countries (D, F, S, NL, CH) and has experience with large industrial customers (VW, Vattenfall, Bouygues and others). In addition to their software solutions, they also offer specially developed charging stations that set standards through the use of advanced technology such as radar sensors and tap payment. The company works with customers from all industry sectors to develop solutions for tomorrow’s mobility needs. Wirelane is one of Europe’s leading specialist providers of hardware, software and app solutions.

virtualQ

Series A in 2018
virtualQ GmbH, founded in 2014 and based in Berlin, Germany, specializes in providing innovative call waiting services for call centers and hotlines. The company offers a Call-In and Call-Back solution that effectively eliminates waiting times, balancing excellent customer service with cost efficiency. During peak periods, virtualQ holds the caller's place in line when wait times exceed a specified threshold. Callers receive notifications when it is their turn and are subsequently connected to the next available agent. The virtualQ service is accessible through various platforms, including voice, web, and mobile applications, enhancing the overall customer experience.

Soley

Series A in 2018
Soley is focused on the development of software solutions for data analysis in the engineering fields. Its solutions focus on product management, test case management, and product architecture analysis. Soley was founded in 2013 as a spin-off company of the Chair of Product Development at the Technical University of Munich (TUM). The four entrepreneurs, mechanical engineers and computer scientists, were enthusiastic about the idea of quickly and efficiently designing the handling of complex data sets in strongly networked subject areas such as product development and product management. Soley provides businesses with solutions and applications to automate their processes and workflows. Soley was founded by Maximilian Kissel in 2013. It is based in Munich, Germany.

casavi

Venture Round in 2018
casavi GmbH is a Munich-based company that operates a digital customer engagement platform specifically designed for property management and residential real estate companies. The platform serves as a customer communication and service portal, enabling these organizations to interact with their clients more effectively and efficiently. By leveraging various digital channels, including mobile, web, and email, casavi facilitates both inbound and outbound communication, acting as a virtual front desk. The solution integrates seamlessly with existing enterprise resource planning (ERP) and customer relationship management (CRM) systems, enhancing workflows and synchronizing data to improve overall customer service.

Userlane

Series A in 2018
Userlane automates user onboarding and employee training with interactive guides to help companies boost trial conversion, reduce support cost & increase user engagement. Userlane provides a technology to create step-by-step guides within minutes, without any coding or having to change the underlying software. This allows online businesses to implement and adapt interactive guides in every part of their existing software without implementation effort.

Asana Rebel

Series A in 2018
Asana Rebel offers a Yoga-inspired fitness app combining the best of Yoga and fitness. The mobile fitness App is available in six languages (DE, EN, FR, PT, ESP, IT), has been featured multiple times by Apple and Google and is rated as one of the top health and fitness apps, with an average of more than 4.6 / 5 stars. The startup was founded in 2015 by Pascal Klein and Robin Pratap and is based in Berlin.

node.energy

Venture Round in 2017
node.energy GmbH is a software-as-a-service company that specializes in the optimization of local energy micro grids for commercial and industrial real estate. Founded in 2016 and headquartered in Frankfurt am Main, Germany, node.energy provides the opti.node application, which enables businesses with on-site power generation to effectively reduce energy costs and minimize their carbon dioxide emissions. The company's solutions support energy managers and metering service providers by significantly reducing administrative burdens and ensuring compliance with current regulations. Additionally, node.energy offers features such as electricity tax relief analysis and automated reporting, alongside planning and advisory services, to facilitate companies' energy transitions and enhance their operational efficiency.

MessengerPeople

Series A in 2017
MessengerPeople GmbH, founded in 2015 in Munich, Germany, specializes in software solutions for messenger communication, enabling businesses to interact with customers through popular messaging apps such as WhatsApp, Facebook Messenger, Apple Business Chat, Telegram, and Viber. The company, originally named WhatsBroadcast GmbH, rebranded in July 2018 and has since established itself as a leading Software-as-a-Service provider in the professional messenger services sector. MessengerPeople's platform allows for efficient management of customer inquiries while ensuring compliance with data protection regulations. Serving a diverse clientele, the company supports approximately 1,800 organizations, including businesses, cities, communities, associations, and political parties across more than 60 countries. With a team of 65 employees from 12 different countries, MessengerPeople continues to innovate in the field of customer communication.

cloudplan GmbH

Series A in 2017
cloudplan GmbH develops a Software-as-a-Service application that connects PCs and servers of a company to a data storage network. Its application allows companies to build their private network storage, organize backups, and integrate cloud storage. The company also designs file/storage and management product that allows users to manage data. cloudplan GmbH is based in Hamburg, Germany.

Volterion

Series A in 2017
Volterion GmbH manufactures and sells compact size redox flow batteries for private homes for the storage of renewable energies. The company offers redox flow stacks, redox flow modules, and redox flow systems. The company was founded in 2015 and is headquartered in Dortmund, Germany.

Cardior Pharmaceuticals

Series A in 2017
Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in the development of non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is the leading cause of death in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor designed to target a critical microRNA that regulates harmful changes in the heart resulting from stress or injury. Cardior Pharmaceuticals is positioned as a planned academic spin-off, emphasizing innovative approaches to address significant cardiovascular health challenges.

KSK Diagnostics

Series A in 2017
KSK Diagnostics GmbH develops molecular point-of-care diagnostic assays in Hamburg. The company focuses on the development of point-of-care-tests for molecular diagnostic of infectious diseases and cancer based on isothermal amplification technology. It also offers customizable services of nucleic acid-based test developments based on real-time PCR or RT-PCR, verification and validation studies, and product enhancement services for other companies. The company was founded in 2014 and is based in Hamburg, Germany.

fodjan GmbH

Series A in 2017
fodjan GmbH provides feed management and ration calculation software for dairy farmers and consultants. The company offers fodjan, which calculates possible fodder rations for the dairy company and arranges them clearly, as well as rates all rations in regard of their feed health and makes proposals to improve the rations based on actual scientific knowledge. Its software is used by companies with consultant and companies without consultant. The company was founded in 2014 and is based in Dresden, Germany.

HepaRegeniX

Series A in 2016
HepaRegeniX GmbH is a biopharmaceutical company based in Ulm, Germany, focused on developing innovative drugs for the treatment of acute and chronic liver diseases. Founded in 2016, the company’s therapeutic approach is centered on a proprietary molecular target known as Mitogen-Activated Protein (MAP) Kinase 4. Research conducted by Professor Lars Zender and his team at the University Hospital Tübingen highlighted MKK4 as a crucial regulator of liver regeneration. Their findings indicated that small RNA molecules could suppress MKK4 gene expression, thereby restoring the regenerative capacity of hepatocytes even in severely affected livers. HepaRegeniX is specifically working on small-molecule inhibitors of MKK4, with potential applications in treating conditions such as nonalcoholic steatohepatitis.

AudioCure Pharma

Series A in 2016
AudioCure Pharma GmbH develops drugs for neurodegenerative disease indications. AudioCure Pharma GmbH was incorporated in 2010 and is based in Berlin, Germany.

VMRay

Series A in 2016
The VMRay Platform is a breakthrough solution for dynamic analysis of advanced threats, including zero day and targeted attacks. By surmounting inherent flaws that plague other products, VMRay Analyzer has become the gold standard for malware sandboxing among leading DFIR teams worldwide. The core of the VMRay Platform is an agentless, hypervisor-based sandbox, which is unique in combining near-total evasion resistance with full visibility into malware behavior: a trait we call X-Ray Vision. Because nothing touches or modifies the analysis environment, monitoring is invisible, and even the most evasive malware strains fully execute in the sandbox. By monitoring every interaction between malware and the target system, VMRay captures a complete and accurate record of threat behavior – data that enriches detection, incident response, digital forensics, and threat intelligence. VMRay Intelligent Monitoring excels over other solutions in distinguishing between malicious behavior and legitimate activity. As a result, VMRay Analyzer delivers precise, noise-free output that reduces false positive rates to near zero. This shortens investigations, enhances efficiency and prevents legitimate traffic from being blocked

Immunic Therapeutics

Series A in 2016
Immunic Therapeutics is a clinical-stage biopharmaceutical company focused on developing selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. Its primary product, IMU-838, is a selective immune modulator currently in Phase 2 clinical trials for ulcerative colitis, relapsing-remitting multiple sclerosis, and Crohn's disease. Additionally, the company is advancing IMU-935, an inverse agonist targeting RORgt, and IMU-856, which aims to restore intestinal barrier function in patients with conditions such as inflammatory bowel disease and irritable bowel syndrome. Immunic Therapeutics is headquartered in New York, New York, and seeks to provide effective treatment options for a range of chronic inflammatory conditions through its innovative drug development initiatives.

Rigontec

Series A in 2016
Rigontec GmbH is a biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The company develops ImOl100, a compound stimulating the immune receptor retinoic acid-inducible gene I, which recognizes viral RNA. Its ImOl100 is also a minimal mimic of naturally occurring 3pRNA, a motif typically occurring in viral RNAs. The company’s compounds avoid the pitfalls of cancer vaccines, checkpoint inhibitors, and therapeutics based on the identification of tumor antigens. Rigontec GmbH was founded in 2014 and is based in Planegg, Germany. As of October 26, 2017, Rigontec GmbH operates as a subsidiary of Merck & Co., Inc.

Reactive Robotics

Series A in 2016
Reactive Robotics was founded as a GmbH in Munich, Germany, in April 2015. Their team has a combined 12 years of rehabilitation robotics research, vast startup experience and a large clinical network to bring this device to life. They are proud to feature an excellent array of supporters that provide advice on every level required for the successful start-up of a medical technology company. Confirmed advisors provide access to patients, support them in engineering, on legal issues and when dealing with the details of registering a medical device with the authorities.

Cunesoft

Series A in 2016
Cunesoft GmbH is a European leader in cloud-based regulatory software software solutions and services for all segments within the life sciences industry. Cunesoft’s Software as a Service (SaaS) modules are lean but provide a solid functional spectrum based on industry best practices. Compliance requirements are fulfilled while the software can be made available and productively used within 24 hours. Cunesoft is already being used globally by small and medium-sized organizations as well as by divisions within multinational pharmaceutical companies. Reliability, security, compliance and continous innovation are key areas of Cunesoft’s offering.

Amal Therapeutics

Series A in 2016
Amal Therapeutics SA, a biotech company, engages in the research and development of therapeutic vaccines in oncology. It uses its cell penetrating peptide platform to develop and progress therapeutic vaccines in oncology, including cancer vaccines, immunotherapy, and therapeutic cancer vaccines. The company was founded in 2012 and is based in Geneva, Switzerland. As of July 15, 2019, Amal Therapeutics SA operates as a subsidiary of Boehringer Ingelheim GmbH.

Multiphoton Optics GmbH

Series A in 2015
Multiphoton Optics develops and markets 3D printing equipment and software solutions. Its equipment and solutions are used to create products in the fields of photonics, biomedicine, life sciences, and functional materials. Multiphoton Optics offers LithoProf3D, a 3D printing equipment platform, and LithoStream3D and LithoSoft3D, software solutions. The company also provides its customers with prototyping and engineering services, and support for its products. Multiphoton Optics was founded by Ruth Houbertz and Markus Riester in September 2013. It is based in Wurzburg, Germany.

figo

Series A in 2015
figo GmbH develops a software as a Service platform that aggregates financial data for financial institutions. It allows users to access the sources of finance, notification services, security, as well as user and customer management services. figo GmbH was founded in 2012 and is based in Hamburg, Germany. As of March 4, 2020, figo GmbH operates as a subsidiary of FinReach GmbH.

gestigon

Series A in 2015
gestigon GmbH designs and develops a 3D image processing software for body and gesture recognition. The company’s solution is a middleware for pose tracking, gesture recognition, and biometrical features identification. It is used in automotive industry in driver cabins for detailed driver and passenger monitoring. The company offers augmented reality/ virtual reality (AR/VR) interaction design services. Additionally, it allows consumers to control electronic devices without touching them. The company was founded in 2011 and is based in Lübeck, Germany. As of February 28, 2017, gestigon GmbH operates as a subsidiary of Valeo SA.

eWings.com

Series A in 2015
eWings.com GmbH, a travel management company, offers a way to find, book, and manage flights, trains, and hotels via web and mobile. The company was founded in 2013 and is based in Berlin, Germany. As of June 8, 2017, eWings.com GmbH operates as a subsidiary of Hogg Robinson Group plc.

FAZUA

Series A in 2015
FAZUA specializes in developing an e-Bike drive system. Its e-Bike drive system was designed to meet sportive demands and, at the same time to create a natural feeling of non-motorized bike riding. FAZUA was founded in 2013 and is headquartered in Ottobrunn, Bayern, Germany.

OMEICOS Therapeutics

Series A in 2015
OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activate an endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.

Sonormed GmbH

Series A in 2015
Sonormed GmbH develops Tinnitracks, a Web application that allows users to filter music in order to use it for a tinnitus therapy that is endorsed by the neuroscientific findings. Its solution also automatically checks music files to determine the therapeutic potential and informs if any of the tracks are less appropriate for use in treating tinnitus. The company was founded in 2012 and is based in Hamburg, Germany.

Skive

Series A in 2015
Skive is a startup focused on transforming mobile learning for students. It offers a digital education platform accessible from any device, allowing users to create and share multiple-choice questions to aid in exam preparation. The platform curates targeted learning content tailored for various university courses, developed by top students, ensuring users access high-quality study materials. In addition to academic resources, Skive connects students with potential employers, facilitating mobile employer branding opportunities for companies. This dual approach aims to enhance the educational experience while bridging the gap between students and the job market.

Oncgnostics

Series A in 2015
oncgnostics GmbH develops molecular assays based on epigenetic biomarkers which allows early and reliable cancer diagnostics. It develops GynTect, which enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages; and in vitro diagnostic (IVD) tests for screening, therapeutic decision making, and follow-up care in cancer diagnostics. The company was founded in 2012 and is based in Jena, Germany.

gestigon

Series A in 2014
gestigon GmbH designs and develops a 3D image processing software for body and gesture recognition. The company’s solution is a middleware for pose tracking, gesture recognition, and biometrical features identification. It is used in automotive industry in driver cabins for detailed driver and passenger monitoring. The company offers augmented reality/ virtual reality (AR/VR) interaction design services. Additionally, it allows consumers to control electronic devices without touching them. The company was founded in 2011 and is based in Lübeck, Germany. As of February 28, 2017, gestigon GmbH operates as a subsidiary of Valeo SA.

Givve

Series A in 2014
givve® is a FinTech company offering benefit solutions for employees and business partners. Age pyramid, shortage of skilled workers, fluctuation – the labour market situation is facing various challenges. In this development, the position of the employee has changed: In the future it will be the employee who can choose their employer, and not the other way around. The attractiveness of a company decides on its success on the market – and becomes the decisive advantage in the competition with other companies. givve® offers innovative tools for employee motivation solutions.

Rigontec

Series A in 2014
Rigontec GmbH is a biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The company develops ImOl100, a compound stimulating the immune receptor retinoic acid-inducible gene I, which recognizes viral RNA. Its ImOl100 is also a minimal mimic of naturally occurring 3pRNA, a motif typically occurring in viral RNAs. The company’s compounds avoid the pitfalls of cancer vaccines, checkpoint inhibitors, and therapeutics based on the identification of tumor antigens. Rigontec GmbH was founded in 2014 and is based in Planegg, Germany. As of October 26, 2017, Rigontec GmbH operates as a subsidiary of Merck & Co., Inc.

Inventorum

Series A in 2014
Inventorum GmbH, founded in 2012 and based in Berlin, Germany, specializes in developing a point of sale application for retailers and online businesses. The company's software is designed to assist small retailers in managing both their offline and online operations by streamlining daily processes, including point of sale and inventory management. Inventorum's integrated system combines cash management, inventory management, customer support, and e-commerce functionality, offering a comprehensive solution tailored to the needs of small businesses. As of July 2020, Inventorum operates as a subsidiary of Shore GmbH.

Quobyte

Series A in 2014
Quobyte GmbH provides software storage infrastructure services. It offers Quobyte, a data center file system that turns servers into a software storage system; persistent storage for containers; software storage that eliminates data silos; storage for financial modeling and backtesting; and storage for the life sciences and bio IT. Quobyte GmbH was formerly known as Xtreem Storage Systems GmbH. The company was founded in 2013 and is based in Berlin, Germany.

Sablono

Series A in 2014
Sablono is a Berlin-based startup developing software solutions for the digital planning and controlling of complex construction projects. With Sablono's first solution Sablono Onsite, users can monitor and analyse the progress of a project in real-time by using highly detailed schedules than can be updated und verified directly on-site. Sablono is a member of the SAP Start-up Focus Programme and is supported by its partners High-Tech Gründerfonds, Hasso Plattner Ventures and Nemetschek Allplan Systems GmbH. At CeBIT 2014 the company won the first prize of the founders’ competition "IKT Innovativ" awarded by the German Federal Ministry for Economic Affairs.

Ezeep

Series A in 2014
Ezeep GmbH provides a cloud-based print management solution designed for small and medium-sized enterprises. Founded in 2010 and based in Berlin, Germany, Ezeep enables users to manage printers and print documents through its online interface. The service supports wireless printing from various devices, including smartphones, tablets, and laptops, without the need for additional hardware. Ezeep has been a subsidiary of ThinPrint Cloud Services, Inc. since 2015, further enhancing its capabilities in the print management sector.

Desino

Series A in 2014
Desino, a Cologne, Germany-based provider of a wheelchair with dynamic seating system, These dynamic seating systems are already established in the office furniture industry and the company now aims to make this also available to people, who spent the most time in a seating posture.

Scopis

Series A in 2013
Scopis is a developer and manufacturer of clinical navigation system for image guided surgery specializing in laser-based measuring and endoscopic augmented reality. Scopis was founded in August 2010 as a joint spin-off of Charité University Clinic Berlin and Fraunhofer IPK. It received an immediate seed round from German incubator High Tech Gründerfonds (HTGF). The MATRIX POLAR navigation system range was brought on the European market in January 2011. Scopis has since focused on improving the utility of navigation for endoscopic procedures. Notably, the Augmented Reality navigation product MATRIX POLAR AR was launched in August 2011.

Itembase

Series A in 2013
Itembase GmbH, founded in 2011 and based in San Francisco, California, operates a cloud-based shopping manager that allows consumers to store and organize their products along with relevant information such as receipts and invoices. The platform also facilitates the sharing of purchases and experiences on social networks. Additionally, Itembase serves as an e-commerce API integration platform, connecting e-commerce shops with solution providers and enabling them to offer services across multiple shop systems. With over 120,000 e-commerce shops utilizing its services, Itembase focuses on providing tailored solutions that enhance the online shopping experience. The company also hosts, enriches, and provides product identity data, further supporting its role in the e-commerce ecosystem.

Middle Peak Medical

Series A in 2013
Middle Peak Medical is a privately held medical device company focused on the development and commercialization of a novel technology to treat mitral valve disease. The company’s proprietary device has application in both percutaneous catheter-based intervention, and in minimally invasive or open-heart cardiac surgery.

PressMatrix

Series A in 2013
PressMatrix GmbH, based in Berlin, Germany, specializes in digital publishing services aimed at transforming traditional print media into interactive digital formats for various platforms, including tablets and mobile devices. Founded in 2009 and originally named bblabs UG, the company rebranded to PressMatrix GmbH in 2011. It provides a comprehensive publishing solution that includes subscription services, a Workbench for content management, and mobile applications tailored for magazines, books, journals, and catalogs. PressMatrix caters to a diverse clientele, including publishers, agencies, and enterprises, with notable clients such as Georg Thieme Verlag and Carry-On Publishing GmbH. The company employs a proprietary online PDF to app converter, enabling seamless conversion and distribution of content across multiple channels.

Ubermetrics

Series A in 2013
uberMetrics Technologies GmbH offers software as a service media monitoring solutions. The company offers UMT Delta, software as a service tool that connects media monitoring, press review, and crisis communication management from various media channels including TV, radio, print, and the social Web. uberMetrics Technologies GmbH was founded in 2011 and is based in Berlin, Germany.

HQ plus

Series A in 2013
HQ plus GmbH develops and markets web application for the hotel industry. The company offers competition monitoring tool for hotels in the online reservation systems. HQ plus GmbH was founded in 2012 and is based in Berlin, Germany.

Versus

Series A in 2013
Versus is a Berlin-based company that provides a platform for comparing a wide range of subjects, including smartphones and universities, through over 45 million natural language text comparisons in 18 languages. Since its inception in 2011, the platform has seen consistent growth, with traffic increasing by an average of 35% each month, currently attracting 3 million unique visitors monthly. Versus aims to establish itself as a comprehensive, Wikipedia-scale information resource for comparisons. The company has secured $3.8 million in funding from various investors, including Earlybird Venture Capital and others, and operates with a team of 30 employees under the leadership of CEO Ramin G. Far.

CardioSecur

Series A in 2013
Personal MedSystems creates and sells products and services for mobile health and in particular Instant Cardiac Monitoring unparalleled in their innovation, ease-of-use and sophistication of design. Personal MedSystems specializes in high level 12-lead ECG technology generated with reduced electrode systems. Their aim is to develop professional ECG systems that are implemented in personalized applications and used by private individuals. This requires creating exceptional ease of use.

CryoTherapeutics

Series A in 2013
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.

Yorxs

Series A in 2013
Yorxs AG offers bulk diamonds and diamond jewelry through its online portal. It offers colored diamonds, investment diamonds, precious metals, rings, necklaces, pendants, and bracelets. The company was founded in 2011 and is based in Munich, Germany.

SOPAT

Series A in 2013
SOPAT is specialized in the analysis of particulate systems. Our team develops and markets an innovative particle measurement technology for real-time analysis of multi-phase systems.

Advanova

Series A in 2013
ADVANOVA GmbH develops VMobil software that allows medical professionals to access a patient’s complete electronic record on a mobile device. The company was founded in 2012 and is based in Erlangen, Germany.

Outfittery

Series A in 2013
Outfittery provides an online personal shopping service for men. OUTFITTERY’s mission is to take the pain out of shopping for men – as an online version of the “personal shopping”.Their personal style experts put together two or three outfits for each of their customers based on their preferences and personality from a range of top brands. Each customer is served and advised personally after a first online contact and an (optional) phone call. They keep the range of clothes constantly up to date by looking for the most interesting men´s fashion brands and the best items of popular designers worldwide.Their service is free and the individually selected items are sent to their customers free of charge. Customers only pay for the pieces that they want to keep in their wardrobe and feel comfortable in. OUTFITTERY today is the pioneer and market leader in curated shopping for men in Europe, shipping to eight countries (Germany, Austria, Switzerland, Netherlands, Belgium, Luxemburg, Sweden and Denmark).

Drug Response Dx

Series A in 2013
Drug Response Dx is based in Hennigsdorf, Germany and was founded in February 2012 by Dr. Zoltán Konthur, Dr. Jörg-M. Hollidt, Dr. Karl Skriner and Dr. Joachim Rautter. The biomarker set is prevalidated; the biochemicals and test samples are present. The proof of concept in serums from RA patients is established.